Lee Johnson Capital Management LLC Acquires Shares of 9,091 Danaher Corporation $DHR

Lee Johnson Capital Management LLC acquired a new position in Danaher Corporation (NYSE:DHR) in the 2nd quarter, Holdings Channel reports. The firm acquired 9,091 shares of the conglomerate’s stock, valued at approximately $6,546,000. Danaher accounts for approximately 2.0% of Lee Johnson Capital Management LLC’s investment portfolio, making the stock its 13th largest position.

A number of other large investors have also recently modified their holdings of the stock. Main Street Group LTD bought a new stake in Danaher during the 1st quarter valued at approximately $25,000. N.E.W. Advisory Services LLC bought a new position in Danaher in the second quarter worth $25,000. JPL Wealth Management LLC purchased a new position in Danaher during the third quarter valued at $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the fourth quarter valued at $26,000. Finally, WFA of San Diego LLC purchased a new stake in shares of Danaher in the 2nd quarter worth about $26,000. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. UBS Group lowered their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. TD Cowen lowered their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. JPMorgan Chase & Co. cut their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Finally, Wells Fargo & Company dropped their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Price Performance

Shares of DHR opened at $202.44 on Tuesday. The company has a market capitalization of $142.31 billion, a P/E ratio of 35.96, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a 50 day moving average of $193.52 and a 200 day moving average of $192.67.

Danaher (NYSE:DHR) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s revenue was up 5.5% compared to the same quarter last year. During the same period last year, the business posted $0.77 EPS. As a group, equities research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.